Credit Suisse maintains Cosmos Pharmaceutical Corp at 'neutral' with a price target of JPY15500.00 June 9, 2023 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Credit Suisse maintains Sysmex Cor at 'outperform' with a price target of JPY10000.00 Back: All Posts Next:Credit Suisse maintains BayCurrent Consult at 'neutral' with a price target of JPY4300.00